300181.SZ
300181.SZ
CNE100001096
ZUO LI YAO YE
Loading chart...

Company Profile

Zhejiang Jolly Pharmaceutical Co.,LTD engages in the research, production, and marketing of Chinese medicinal products in the People's Republic of China and internationally. The company offers Wuling capsule to treat insomnia, amnesia, heart palpitations, lack of energy, lassitude in loin and legs, and giddy tinnitus, as well as deficiency of energy and weak pulse caused by the disharmony of heart and kidney, or neurasthenia. It also provides Lingze tablet, which is used to treat frequent urination, dysuria, weak steam of urine, endless urine, and soreness and weakness of waist and knees caused by benign prostatic hyperplasia, kidney deficiency, and blood stasis; and Bailing tablet that is used as the adjuvant therapy to treat cough, asthma, back pain, and chronic bronchitis, which are caused by the deficiency of lungs and kidney. In addition, the company offers Linglianhua particles for the treatment of symptoms, including sweating, insomnia, dysphoria, heart palpitations, dreaminess, giddy tinnitus, lassitude in loin and legs, dry stool, and abnormal furred tongue, as well as weak pulse caused by perimenopausal syndrome, or disharmony of heart and kidney. Further, it provides azithromycin, clindamycin phosphate, doxapram, pefloxacin mesylate, adenosine cyclophosphate, and sodium nitroprusside injections. Additionally, it offers materials, such as cephalosporin sinensis, fermented cordyceps, and Wuling powders. It invests and participates in the medical services of Deqing No.3 People's Hospital. The company was formerly known as Zhejiang Jolly Pharmaceutical Health Products Co., LTD. and changed its name to Zhejiang Jolly Pharmaceutical Co.,LTD in 1998. The company was founded in 1995 and is based in Huzhou, China.

Related stocks

600713.SS
600713.SS • China
NANJING PHARMACEUTICAL GP CO LT
5.14 CNY
1.01B USD 1Y +3.6%
600771.SS
600771.SS • China
GUANGYUYUAN CHINESE HERBAL MEDI
14.38 CNY
1.05B USD 1Y -24.5%
300357.SZ
300357.SZ • China
WOLWO PHARMA
19.99 CNY
1.57B USD 1Y -30.7%
002019.SZ
002019.SZ • China
YIFAN PHARM
9.66 CNY
1.76B USD 1Y -30.7%
PFIZER.NS
PFIZER.NS • India
PFIZER LTD
3,808.2 INR
1.8B USD 1Y -27.7%
H02.SI
H02.SI • Singapore
Haw Par
12.77 SGD
2.21B USD 1Y -13.6%
RUBICON.NS
RUBICON.NS • India
RUBICON RESEARCH LIMITED
1,548.5 INR
2.65B USD
KLBF.JK
KLBF.JK • Indonesia
Kalbe Farma Tbk
785 IDR
1.99B USD 1Y -27.6%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
45.1% p.a.
Max Drawdown (5Y)
-42.8%
Sharpe Ratio (5Y)
0.13
Beta Factor
0.16
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (45.1% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -69.7% in the extended horizon.
ende